Veracyte, Inc. VCYT 深 滬
已收盤 02-06 16:00:00 美东时间
36.19
+1.330
+3.82%
華盛通- 最 高36.50
- 今 開35.67
- 成交量 120.35万股
- 最 低 34.71
- 昨 收 34.86
- 總市值 28.61亿
- 52周最高 50.71
- 市盈率 靜 117.20
- 換手率 1.52%
- 52周最低 22.61
- 委 比 1.36%
- 總股本 7904.92万
- 歷史最高 86.03
- 量 比 1.24
- 振 幅 5.13%
- 歷史最低 4.21
- 每 手 1
- 風險率 6.41%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Reported Earlier, Veracyte Reports Preliminary FY2025 Revenue Of $515M–$517M Up ~16% YoY With Strong Testing Volume Growth, Q4 Revenue Of $138M–$140M And Introduces 2026 Revenue Outlook Of $570M–$582M
For the fourth quarter ended December 31, 2025, as compared to the same period of 2024, Veracyte expects to report:Total revenue of between $138 million and $140 million, an increase of between 16% and 18%Testing revenue
01-12 15:19
美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
Guggenheim Maintains Buy on Veracyte, Raises Price Target to $50
Guggenheim analyst Subbu Nambi maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $45 to $50.
01-06 01:04
Smart Oncology: 5 Stocks Chasing the $317B Prize
Issued on behalf of Oncolytics Biotech Inc. USANewsGroup.com News Commentary VANCOUVER, BC, Dec. 31, 2025 /PRNewswire/ -- The precision oncology market surged to $139.4 billion in 2025 and i...
2025-12-31 20:25
Meihua International Medical Technologies, Fly-E Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around...
2025-12-08 21:03
美股大行评级 | 最高500美元！MongoDB获18家大行紧急上调目标价；巴克莱下调理想汽车目标价至18美元
今日重点评级关注：B. Riley证券：维持Seabridge Gold"买入"评级，目标价从50美元升至65美元；HC Wainwright & Co.：维持TRX Gold"买入"评级，目标价从1.2美元升至1.4美元
2025-12-03 09:58
Morgan Stanley Maintains Underweight on Veracyte, Raises Price Target to $48
Morgan Stanley analyst Tejas Savant maintains Veracyte (NASDAQ:VCYT) with a Underweight and raises the price target from $40 to $48.
2025-12-03 02:02
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
2025-11-12 11:43
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
2025-11-07 10:14
美股牛股 | Solid Power飙升超51%！与宝马及三星SDI合作推进全固态电池技术商业化；Lemonade涨超34%
Solid Power飙升超51%！与宝马及三星SDI合作推进全固态电池技术商业化；Lemonade涨超34%，Q3业绩大幅超预期并上调业绩指引>>
2025-11-06 15:10
